My ePortfolio Register   

Brain metastases: a role of conventional chemotherapy?

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 17.05.17
Views: 713

Dr Peter Mohr - Elbe Klinikum Buxtehude, Germany

Dr Mohr speaks with ecancer at EADO 2017 about the suitability of chemotherapy for brain metastases of skin cancer.

He notes ongoing research into combining chemotherapy with immunotherapy, and in the adjuvant setting, but ultimately chemotherapeutics offer no survival benefit.

This does mean that patients with brain metastases may be more readily considered eligible for trials of new agents, but Dr Mohr cautions against any further use of chemotherapy beyond last-line and salvage efforts.

ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence